1. Home
  2. TK vs SPRY Comparison

TK vs SPRY Comparison

Compare TK & SPRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Teekay Corporation

TK

Teekay Corporation

HOLD

Current Price

$12.00

Market Cap

937.1M

ML Signal

HOLD

Logo ARS Pharmaceuticals Inc.

SPRY

ARS Pharmaceuticals Inc.

HOLD

Current Price

$8.07

Market Cap

761.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TK
SPRY
Founded
1973
2015
Country
Bermuda
United States
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
937.1M
761.6M
IPO Year
1995
2020

Fundamental Metrics

Financial Performance
Metric
TK
SPRY
Price
$12.00
$8.07
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$40.00
AVG Volume (30 Days)
544.1K
1.3M
Earning Date
05-06-2026
03-09-2026
Dividend Yield
16.88%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$84,278,000.00
Revenue This Year
N/A
$90.76
Revenue Next Year
N/A
$81.70
P/E Ratio
$13.43
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.65
$6.66
52 Week High
$13.76
$18.63

Technical Indicators

Market Signals
Indicator
TK
SPRY
Relative Strength Index (RSI) 54.04 41.76
Support Level $9.11 $6.66
Resistance Level $13.76 $10.44
Average True Range (ATR) 0.43 0.59
MACD -0.02 0.01
Stochastic Oscillator 62.56 36.68

Price Performance

Historical Comparison
TK
SPRY

About TK Teekay Corporation

Teekay Corp Ltd provides international crude oil marine transportation and other marine services. It also offers offshore oil production, storage, and offloading services, under long-term, fixed-rate contracts. The company has two primary lines of business: Marine services and tankers. It manages these businesses for the benefit of all stakeholders. The company serves energy and utility companies, oil traders, large oil and LNG consumers, petroleum product producers, government agencies, and various other entities that depend upon marine transportation.

About SPRY ARS Pharmaceuticals Inc.

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the commercialization and development of neffy (currently identified in the European Union (EU) and United Kingdom (U.K.) by the trade name EURneffy and in China) for needle-free intranasal delivery of epinephrine for emergency treatment of Type I allergic reactions, including anaphylaxis. Neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows Neffy to safely provide intranasal delivery of epinephrine at a low dose within the exposures of approved injectable products across a range of dosing conditions.

Share on Social Networks: